Aviva PLC reduced its position in Balchem Co. (NASDAQ:BCPC – Get Rating) by 36.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,603 shares of the basic materials company’s stock after selling 4,409 shares during the quarter. Aviva PLC’s holdings in Balchem were worth $928,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. raised its position in shares of Balchem by 1.7% in the third quarter. BlackRock Inc. now owns 4,900,490 shares of the basic materials company’s stock valued at $595,802,000 after buying an additional 83,220 shares during the last quarter. Vanguard Group Inc. grew its stake in Balchem by 7.3% during the 3rd quarter. Vanguard Group Inc. now owns 3,862,027 shares of the basic materials company’s stock valued at $469,545,000 after acquiring an additional 261,534 shares in the last quarter. State Street Corp raised its holdings in Balchem by 1.7% in the 3rd quarter. State Street Corp now owns 1,067,814 shares of the basic materials company’s stock valued at $129,825,000 after acquiring an additional 17,532 shares during the last quarter. Conestoga Capital Advisors LLC raised its holdings in Balchem by 0.7% in the 4th quarter. Conestoga Capital Advisors LLC now owns 1,040,578 shares of the basic materials company’s stock valued at $127,065,000 after acquiring an additional 7,062 shares during the last quarter. Finally, Geneva Capital Management LLC lifted its stake in Balchem by 3.3% in the 4th quarter. Geneva Capital Management LLC now owns 750,324 shares of the basic materials company’s stock worth $91,622,000 after purchasing an additional 23,776 shares in the last quarter. Hedge funds and other institutional investors own 89.29% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently commented on BCPC. StockNews.com started coverage on Balchem in a report on Thursday. They issued a “hold” rating for the company. HC Wainwright reduced their price target on Balchem from $152.00 to $140.00 in a report on Monday, February 27th.
Insider Buying and Selling
Balchem Stock Performance
NASDAQ:BCPC opened at $124.17 on Monday. The company’s 50-day moving average is $126.47 and its two-hundred day moving average is $129.83. Balchem Co. has a 1-year low of $110.15 and a 1-year high of $143.88. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.88 and a quick ratio of 1.81. The firm has a market capitalization of $4.00 billion, a price-to-earnings ratio of 40.58 and a beta of 0.70.
Balchem (NASDAQ:BCPC – Get Rating) last released its quarterly earnings data on Friday, April 28th. The basic materials company reported $0.70 EPS for the quarter, missing analysts’ consensus estimates of $0.78 by ($0.08). The business had revenue of $232.54 million during the quarter, compared to analyst estimates of $232.00 million. Balchem had a net margin of 10.48% and a return on equity of 10.69%. During the same quarter in the prior year, the company posted $0.89 earnings per share. Analysts forecast that Balchem Co. will post 3.6 EPS for the current year.
Balchem Company Profile
Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems.
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Get Rating).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.